Hospital-Acquired Infection Diagnostics Market Share, Size, Future Demand, and Emerging Trends One of the major causes of morbidity and mortality in hospitalized patients presently are hospital-acquired infections (HAI), according to the World Health Organization. Also known as nosocomial infections, HAIs are mostly caused due to bacteria. As antibiotics are utilized frequently within hospital settings, the types of bacteria and their resistance to antibiotics is different than that of bacteria outside of the hospital. HAIs result in an enormous rise in the cost of the hospital care and further leads to the emergence of new health hazards for the community. While some advances have been made when it comes to controlling infections spreading in hospitals, advancements in therapeutics and biomedical technology are further producing larger number of highly susceptible patients. Ascribed to this, the need for HAI diagnostics is increasing rapidly. According to a report by P&S Intelligence, in 2016, the global hospital-acquired infection diagnostics market attained a value of $2,657.6 million and is expected to reach a value of $4,386.6 million by 2023, progressing at a 7.6% CAGR during the forecast period (2017–2023). The products used for diagnosing HAIs are instruments and reagents & consumables, between which, the demand for reagents & consumable was higher due to the expansion in the molecular diagnostic testing volumes. Different HAI infection types are hospital acquired pneumonia, gastrointestinal infections, urinary tract infections (UTI), bloodstream infections, and surgical site infections. In 2017, hospital acquired UTIs were caused the most. This infection is generally caused because of medical devices such as due to the improper utilization of catheters. As per the Centers for Disease Control and Prevention, 75% hospital acquired UTIs are associated with urinary catheters. In addition to this, the prevalence of hospital acquired gastrointestinal infections is also projected to increase in the coming years. Get More Insights: https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market North America is expected to emerge as the largest hospital-acquired infection diagnostics market in the coming years, which is attributed to the well-developed healthcare industry, growing number of patients suffering from nosocomial infections, and presence of major hospital acquired infections diagnostics manufacturers in the region. In addition, many technological advancements are taking place in the medical field which have made diagnosis processes easy and more accurate. Innovations in the field such as mass spectrometry, nucleic acid-based technologies, floe cytometry, near-infrared spectroscopy, and isothermal microcalorimetry are extensively being adopted for the diagnosis of infectious diseases. Hence, the demand for HAI diagnosis is rising because of the rising prevalence of infectious diseases and technological advancements.